Effects of a distal protection device during primary stenting in patients with acute anterior myocardial infarction

Circulation Journal

Volumn 68, Issue 8, 2004, Pages 763-768

  Nakamura, Tomohiro ^a   Kubo, Norifumi ^a   Seki, Yuichi ^a   Ikeda, Nahoko ^a   Ishida, Takeshi ^a   Funayama, Hiroshi ^a   Hashimoto, Shigemasa ^a   Yasu, Takanori ^a   Fujii, Mikihisa ^a   Kawakami, Masanobu ^a   Saito, Muneyasu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Distal protection device; Reperfusion

Indexed keywords

CREATINE KINASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BALLOON OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DEVICE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE WALL MOTION; HEART VENTRICULOGRAPHY; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; THROMBECTOMY; TRANSLUMINAL CORONARY ANGIOPLASTY;

BLOOD FLOW VELOCITY; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 3843093681     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.763     Document Type: Article

References (33)

1. White HD, Norris RM, Brown MA, Takayama M, Maslowski A, Bass NM, et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med 1987; 317: 850-855.
2. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-679.
3. The GUSTO angiographic investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-1622.
4. Lincoff AM, Topol EJ. Illusion of reperfusion: Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993; 88: 1361-1374.
5. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-772.
6. Grines CL, Cox DA, Stone GW, Gracia E, Matton LA, Giambartolomei A, et al for the Stent Primary Angioplasty in Myocardial Infarction Study Group. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999; 341: 1949-1956.
7. Maillard L, Hamon M, Khalife K, Steg PG, Beygui F, Guermonprez JL, et al for the STENTIM-2 Investigators. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000; 35: 1729-1736.
8. Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, Oki Y, et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J 1995; 130: 239-243.
9. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000; 36: 1202-1209.
10. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, et al. Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992; 85: 1699-1705.
11. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994; 89: 2514-2518.
12. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101: 570-580.
13. Kotani J, Nanto S, Mintz GS, Kitakaze M, Ohara T, Morozumi T, et al. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002; 106: 1672-1677.
14. Anzai H, Yoneyama S, Tsukagoshi M, Miyake T, Kikuchi T, Sakurada M. Rescue percutaneous thrombectomy system provides better angiographic coronary flow and does not increase the in-hospital cost in patients with acute myocardial infarction. Circ J 2003; 67: 768-774.
15. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, et al on behalf of the Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronay bypass grafts. Circulation 2002; 105: 1285-1290.
16. The TIMI study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med 1985; 312: 932-936.
17. Gibson CM, Cannon CP, Daley WL, Dodge JT, Alexander B, Marble SJ, et al for the TIMI 4 study group. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-888.
18. van't Hof AWJ, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zilstra F, The Zwolle Myocardial Infarction Study Group. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Circulation 1998; 97: 2302-2306.
19. Sheehan FH, Mathey DG, Schofer J, Krebber H, Dodge HT. Effect of intervention in salvaging left ventricular function in acute myocardial infarction: A study of intracoronary streptokinase. Am J Cardiol 1983; 52: 431-438.
20. Genda S, Miura T, Miki T, Ichikawa Y, Shimamoto K. K (ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia. J Am Coll Cardiol 2002; 40: 1339-1346.
21. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999; 33: 654-660.
22. Werner GS, Lang K, Kuehnert H, Figulla HR. Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv 2002; 57: 444-451.
23. Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000; 101: 2154-2159.
24. Limbruno U, Micheli A, De Carlo MD, Amoroso G, Rossini R, Palagi C, et al. Mechanical prevention of distal embolization during primary angioplasty: Safety, feasibility, and impact on myocardial reperfusion. Circulation 2003; 108: 171-176.
25. Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E for the TIMI study group. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 2002; 105: 1909-1913.
26. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002; 39: 591-597.
27. Haager PK, Christott P, Heussen N, Lepper W, Hanrath P, Hoffmann R. Prediction of clinical outcome after mechanical revasculariztion in acute myocardial infarction by markers of myocardial reperfusion. J Am Coll Cardiol 2003; 41: 532-538.
28. Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J 2003; 145: 42-46.
29. Grube E, Gerckens U, Yeung AC, Rowold S, Kirchhof N, Sedgewick J, et al. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 2001; 104: 2436-2441.
30. Ikeda N, Yasu T, Kubo N, Hashimoto S, Tsuruya Y, Fujii M, et al. Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction. Heart 2004; 90: 181-185.
31. Sugimoto K, Ito H, Iwakura K, Ikushima M, Kato A, Kimura R, et al. Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction. Circ J 2003; 67: 295-300.
32. Hayashi M, Tsutamoto T, Wada A, Maeda K, Mabuchi N, Tsutsui T, et al. Intravenous atrial antriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 2001; 37: 1820-1826.
33. Kuga H, Ogawa K, Oida A, Taguchi I, Nakatsugawa M, Hoshi T, et al. Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction. Circ J 2003; 67: 443-448.